GLP-1 & Peptide Merchant Accounts in 2026: How to Get Approved (and Stay Approved)
The GLP-1 and peptide market has grown faster than most standard processors can underwrite for, and merchants selling semaglutide, tirzepatide, or research peptides are getting frozen out or shut down mid-processing at a higher rate than almost any other telehealth category. Getting a stable account isn't about a workaround — it's about meeting three specific requirements underwriters now check by default: LegitScript certification, a clear FDA-approved-vs-compounded position, and documentation that matches what's actually happening at checkout.
If you haven't already ruled out standard aggregators, our guide to Stripe alternatives for high-risk businesses covers why Stripe, Square, and PayPal won't board prescription-adjacent products in the first place. This article picks up from there — what a GLP-1 or peptide program specifically needs to get approved and stay approved.
LegitScript Certification Is Now the Price of Entry
For GLP-1, weight-loss, and prescription-adjacent telehealth models, LegitScript Healthcare Merchant Certification has moved from "helpful" to functionally mandatory. Google and Meta require it before they'll approve healthcare or pharmaceutical advertising, and Visa and Mastercard require it for the merchant category codes that cover this vertical. Without it, most sponsor banks won't underwrite the account at all, regardless of how clean the rest of your application looks.
Certification isn't instant. Expect a one-time application fee in the ballpark of $975 per website, an annual certification fee of roughly $2,150, and a review window that runs anywhere from a few weeks to a few months depending on how complex your clinical and fulfillment model is. Processors that partner directly with LegitScript can sometimes shorten that timeline, which is worth asking about if you're trying to launch on a deadline.
If your program also dispenses through a compounding or specialty pharmacy, LegitScript sits alongside NABP accreditation and DSCSA traceability requirements — our compounding and specialty pharmacy page covers that layer in more depth.
What Underwriters Are Actually Looking For
High-risk underwriters for this vertical read your website, your fulfillment chain, and your billing practices as one connected story — not as separate checkboxes. The models that stay boarded share a consistent structure: licensed prescribers, licensed pharmacy partners, and real clinical gating before a sale happens. The ones that get declined or shut down usually skip one of those three.
Documentation underwriters typically expect includes:
- Entity verification: articles of incorporation, EIN letter, ownership IDs, and several months of business bank statements
- Active LegitScript certificate, renewal date, and the exact URL scope it covers
- Prescriber agreements and pharmacy or compounding partner contracts, with licensing summaries for every state served
- Published refund, cancellation, and subscription-billing policies that match what actually happens at checkout
- Chargeback history (if any) plus the tools in place to manage disputes — Ethoca or Verifi alerts, velocity limits, clear billing descriptors
One distinction underwriters now weigh heavily: whether the product is FDA-approved or compounded. Compounded-heavy models generally face higher reserves or tighter volume caps than clinics dispensing only commercially available drugs, and any site that blurs the line between the two — without clear prescribing criteria — tends to fail underwriting before a human ever reviews an application.
If your intake flow collects PHI, HIPAA and BAA requirements apply on top of this — see our telemedicine payment gateway guide for how that layer is handled separately from the card-processing underwriting above.
What Approval Actually Costs
Rates and terms vary by processor and risk profile, but the ranges underwriters are quoting for compliant GLP-1 and peptide programs in 2026 tend to fall around:
| Term | Typical Range |
|---|---|
| Processing rate | 3.5%–6.0% + $0.25–$0.35 per transaction |
| Rolling reserve | 10%–15%, held 6–12 months |
| Monthly minimum | $25–$50 |
| Approval timeline | 7–14 business days (add 2–4 weeks if LegitScript certification is still in progress) |
Rates and reserves usually come down once you can show a clean processing history, active LegitScript certification, and a low chargeback ratio — none of which happen overnight, so it's worth building the compliance case before you apply rather than after a decline.
A Red Flag Worth Knowing About
Because demand in this space has outpaced the number of banks willing to underwrite it, a market of intermediaries has grown up around it — some legitimate, some not. If a processor or ISO tells you that you've been approved off a "thin" application, without ever showing you your actual merchant agreement or the merchant category code you were boarded under, treat that as a serious warning sign. Some of these arrangements are informal payment-facilitator setups operating outside normal card network structure, which can leave a merchant with little protection if funds are held or the arrangement collapses. A processor willing to underwrite this category properly has no reason to hide how the account is structured.
The Bottom Line
GLP-1 and peptide merchants can absolutely get stable, long-term processing in 2026 — but it requires treating compliance as infrastructure, not an afterthought: FDA-approved products (or clearly compliant compounded pathways), active LegitScript certification, licensed prescribers and pharmacy partners, and a processor that specializes in underwriting this exact category rather than a generalist aggregator.
Comparing providers who actually specialize in GLP-1 and telehealth underwriting — rather than applying blind and hoping for the best — is the fastest way to avoid a frozen account down the line. Compare high-risk merchant account providers built for regulated healthcare and telehealth models before you apply.
Frequently Asked Questions
Do I need LegitScript certification to process GLP-1 payments?
In practice, yes. Visa and Mastercard require it for the relevant merchant category codes, and Google and Meta require it to run healthcare or pharmaceutical advertising. Without it, most sponsor banks will decline the application outright.
Can I use Stripe, Square, or PayPal for a GLP-1 or peptide business?
No. These are payment aggregators that classify prescription and prescription-adjacent products as prohibited or restricted, and accounts in this category are routinely frozen once their risk models flag the activity.
What's the difference between compounded and FDA-approved GLP-1 processing?
Underwriters treat them differently. FDA-approved products dispensed by licensed pharmacies are the more straightforward approval path. Compounded products can still be boarded, but typically come with higher reserves, tighter volume caps, and closer ongoing monitoring.
How long does it take to get approved?
A clean application with active LegitScript certification typically takes 7–14 business days to underwrite. If certification is still pending, add 2–4 weeks on top of that.
Why do GLP-1 merchant accounts carry higher reserves?
Subscription billing, high average tickets, and card-not-present sales all increase dispute exposure, and prescription-adjacent products add regulatory risk on top of that. Reserves are the processor's way of pricing that exposure rather than declining the account outright.
